Sclerotherapy

New York Laser & Skin Care

Sclerotherapy is a well-established, minimally invasive treatment used to reduce the appearance of spider veins and small varicose veins. By injecting a specialized solution directly into the affected veins, the treatment causes them to collapse and gradually fade from view. It is a safe and effective option for restoring clearer, smoother-looking skin.

How Sclerotherapy Works

The injected solution irritates the inner lining of the targeted vein, causing it to close and be reabsorbed by the body over time. Blood flow is naturally redirected to healthier veins, improving both appearance and circulation. The treatment is precise and tailored to each patient’s unique vein pattern.

What to Expect

Sclerotherapy sessions are quick and require little to no downtime. Some patients may experience mild redness or bruising at the injection site, which resolves within days. Over the following weeks, treated veins gradually fade, revealing more even-toned skin.

Dr. Arielle Kauvar

Arielle Kauvar, MD

Dr. Arielle Kauvar is the founding director of New York Laser & Skin Care, a private practice specializing in laser surgery, cosmetic dermatology, Mohs (skin cancer) surgery and clinical research.

She is Clinical Professor of Dermatology at New York University Grossman School of Medicine, a board-certified dermatologist and a leading authority on laser technology, minimally invasive skin rejuvenation and skin cancer treatment.

Dr. Kauvar has pioneered many laser and device-based skin treatments that are commonly used throughout the world and remains actively engaged in the development of new technology and clinical research.  A principal investigator in over 50 clinical trials in all phases of development and the FDA approval process, she has authored over 100 publications, including manuscripts, book chapters and a comprehensive textbook on laser surgery.

She lectures at national and international scientific meetings, is frequently interviewed by the media, and is a consultant to the medical device and pharmaceutical industries.